使用Cleaner XT设备进行动静脉内瘘和移植物的药物机械性溶栓治疗。
Using the Cleaner XT Device for Pharmacomechanical Thrombolysis of Arteriovenous Fistulas and Grafts.
作者信息
Byun Jee Hyuk, Jagannath Preethi, Raja Junaid
机构信息
Department of Radiology, University of Alabama at Birmingham, Birmingham, USA.
出版信息
Cureus. 2025 Aug 20;17(8):e90571. doi: 10.7759/cureus.90571. eCollection 2025 Aug.
PURPOSE
The Cleaner XT (Argon Medical Device, Plano, TX) rotational thrombectomy (RT) device is an emerging treatment option for arteriovenous fistula (AVF) and graft revascularization. This study aims to report the procedural details, safety, efficacy, and patency of AVFs and grafts for endovascular salvage procedures conducted with the Cleaner XT device.
METHODS
All patients who underwent RT with the Cleaner XT RT System for endovascular salvage of AVFs and grafts from August 2016 to July 2022 at a single tertiary hospital were included. Study population, procedure, lesion characteristics, and the patency of AVFs and grafts after endovascular thrombectomy were reported.
RESULTS
Patency after endovascular salvage with Cleaner XT for all 13 patients was 84.6% (11/13) at one-month follow-up and 53.8% (7/13) for all follow-ups until 12 months.
CONCLUSION
This study shows that endovascular access salvage of AVF and graft with Cleaner XT is safe and demonstrates an excellent clinical and technical success rate.
目的
Cleaner XT（氩气医疗设备公司，得克萨斯州普莱诺）旋转血栓切除术（RT）设备是一种用于动静脉内瘘（AVF）和移植物血管重建的新兴治疗选择。本研究旨在报告使用Cleaner XT设备进行血管腔内挽救手术时，AVF和移植物的手术细节、安全性、有效性及通畅率。
方法
纳入2016年8月至2022年7月在一家三级医院使用Cleaner XT RT系统对AVF和移植物进行血管腔内挽救的所有患者。报告研究人群、手术、病变特征以及血管腔内血栓切除术后AVF和移植物的通畅情况。
结果
13例患者使用Cleaner XT进行血管腔内挽救后，1个月随访时通畅率为84.6%（11/13），至12个月的所有随访中通畅率为53.8%（7/13）。
结论
本研究表明，使用Cleaner XT对AVF和移植物进行血管腔内挽救是安全的，且临床和技术成功率极佳。
Zotero 插件